Skip to content

3M™ Transpore™ 1527-1Recalls & reported problems

3m Company · 3M(TM) TRANSPORE SURGICAL TAPE 1527-1 · Class 1

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 30707387065950), received between Feb 18, 2019 and Dec 8, 2021 — classified as 3 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3

Patient problems

  • Local Reaction2
  • Blister1
  • Blood Loss1
  • Rash1
  • Skin Inflammation/ Irritation1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 8, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT DEVELOPED A RASH DESCRIBED AS THE SIZE OF THE PALM OF A HAND AFTER USE OF 3M TRANSPORE SURGICAL TAPE. THE TAPE WAS APPLIED WITH OVERNIGHT WEAR TO SECURE A CATHETER. FUCIDIN(R) 2% CREAM AND TARO-CLOBETASOL 0.05% CREAM WERE PRESCRIBED AND APPLIED TOPICALLY TWICE A DAY AND THE RASH RESOLVED.

    Patient problems: Local Reaction; Rash

    MAUDE report 12962165 ↗
  • InjuryMar 19, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FEMALE CUSTOMER ALLEGED THAT HER 10 YEARS OLD DAUGHTER HAD A SEVERE ALLERGIC REACTION TO THE 3M¿ TRANSPORE¿ SURGICAL TAPE. HER DAUGHTER HAD A WART INFECTION. SHE APPLIED AN OVER THE COUNTER WART MEDICINE (MEDICATION UNSPECIFIED) TO THE AREA BEFORE SHE APPLIED THE TRANSPORE TAPE. THE TAPE WAS APPLIED TO HER LEFT INNER THIGH. SHE USED THE BANDAGE FOR 3 CONSECUTIVE DAYS. THE TAPE WAS IN PLACE FOR ABOUT 16-24 HOURS AND WAS CHANGED DAILY. SHE FIRST NOTICED THE ALLEGED INJURY ON (B)(6) 2021. SHE ALLEGED THE AREA WAS RED, BUBBLY AND LOOKED LIKE A BLISTER. SHE TREATED THE AREAS WITH A STEROID CREAM (TRIAMCINOLONE ACETONITE OINTMENT) THAT WAS PRESCRIBED BY THE DOCTOR. THE ALLEGED INJURY IS RESOLVING. SHE REPORTED THAT HER DAUGHTER IS ALLERGIC TO HAY FEVER AND HAD A PAST ALLERGIC REACTION TO LATEX TAPE AFTER ROUTINE INFANT IMMUNIZATION. NO MEDICAL HISTORY REPORTED.

    Patient problems: Blister; Local Reaction; Skin Inflammation/ Irritation

    MAUDE report 11530090 ↗
  • InjuryFeb 18, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NURSE FROM AN OUTPATIENT DIALYSIS CLINIC REPORTED A PATIENT EXPERIENCED A VENOUS DIALYSIS NEEDLE DISLODGEMENT. THE VENOUS NEEDLE WAS ALLEGEDLY SECURED TO THE PATIENT WITH 3M¿ MICROPORE¿ PLUS PAPER TAPE AND 3M¿ TRANSPORE¿ SURGICAL TAPE. THE NURSE REPORTED THE PATIENT FELL ASLEEP DURING DIALYSIS. WHEN THE PATIENT PULLED UP HIS BLANKET, THE VENOUS NEEDLE GOT CAUGHT, AND WAS PULLED OUT. THE PATIENT ALERTED THE STAFF WHO RESPONDED IMMEDIATELY. THE DIALYSIS MACHINE WAS TURNED OFF. THE ESTIMATED BLOOD LOSS WAS 500CC. APPROXIMATELY ONE-HALF PINT OF BLOOD WAS RETURNED THROUGH THE ARTERIAL DIALYSIS NEEDLE. AN UNSPECIFIED AMOUNT OF SALINE WAS ALSO ADMINISTERED THROUGH THE ARTERIAL DIALYSIS NEEDLE. THE PATIENT WAS ALERT AND ORIENTATED DURING THE ENTIRE EVENT. DIALYSIS WAS DISCONTINUED, THE PATIENT WAS MONITORED, AND WAS EVENTUALLY DISCHARGED HOME. THE PATIENT RETURNED TO THE DIALYSIS CLINIC FOR HIS REGULARLY SCHEDULED ROUTINE DIALYSIS TREATMENTS.

    Patient problems: Blood Loss

    MAUDE report 8347925 ↗

Other Tape and bandage, adhesive devices

All Tape and bandage, adhesive devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page